Currently there is no vaccine to prevent this virus and no specific antiviral therapy to treat HMPV, according to the CDC.

Adults aged 75 years or older should receive an RSV protein subunit vaccine; receipt can be considered for those aged 60 to 74 years at increased risk ...

Human metapneumovirus (HMPV), a respiratory virus with no vaccine and no targeted antiviral treatment, is among the respiratory illnesses currently going around in the United States alongside ...

A virus with no treatment or vaccine is rising in NJ, adding to flu, RSV and COVID cases in NJ. Here's the symptoms, how serious it is and more.

Flu cases are “very high” across much of Idaho, federal health experts say, and another respiratory virus is on the rise as ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...

The political and scientific fight over the COVID vaccines rages on, years later, with the belated acknowledgment by the FDA there were likely a small number of children killed by ...

Respiratory illness thrives in the winter. This year, cases have been high and continue to be quite present, but Michigan appears to be past the season’s highest peak. The blanket term “respiratory ...

Commentary: While vaccines stimulate the body to produce an immune response, monoclonal antibodies skip a few steps and infuse antibodies directly.

Human metapneumovirus could progress to bronchitis or pneumonia. Studies also show dual diagnoses of HMPV, influenza and RSV, ...